Phase I/II study on cytarabine and idarubicin combined with escalating doses of clofarabine in newly diagnosed patients with acute myeloid leukaemia and high risk for induction failure (AMLSG 17-10 CIARA trial).
Saved in:
| Title: | Phase I/II study on cytarabine and idarubicin combined with escalating doses of clofarabine in newly diagnosed patients with acute myeloid leukaemia and high risk for induction failure (AMLSG 17-10 CIARA trial). |
|---|---|
| Authors: | Krauter J; Department of Haematology, Haemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany., Fiedler W; Department of Oncology, Haematology and Bone Marrow Transplantation with section Pneumology, Hubertus Wald University Comprehensive Cancer Centre Hamburg, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany., Schlenk RF; NCT-Trial Centre, National Centre for Tumour Diseases, Heidelberg, Germany., Paschka P; Department of Internal Medicine III, University of Ulm, Ulm, Germany., Thol F; Department of Haematology, Haemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany., Lübbert M; Department of Haematology-Oncology, Faculty of Medicine Freiburg, University of Freiburg Medical Centre, Freiburg, Germany., Wattad M; Evangelisches Krankenhaus Essen-Werden, Essen, Germany., Verbeek M; Department of Internal Medicine III, Technical University of Munich, Munich, Germany., Könecke C; Department of Haematology, Haemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany., Neuhaus B; Hannover Clinical Trial Centre, Hannover Medical School, Hannover, Germany., Papkalla A; Hannover Clinical Trial Centre, Hannover Medical School, Hannover, Germany., Kebenko M; Department of Oncology, Haematology and Bone Marrow Transplantation with section Pneumology, Hubertus Wald University Comprehensive Cancer Centre Hamburg, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany., Janning M; Department of Oncology, Haematology and Bone Marrow Transplantation with section Pneumology, Hubertus Wald University Comprehensive Cancer Centre Hamburg, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany., Döhner K; Department of Internal Medicine III, University of Ulm, Ulm, Germany., Gaidzik VI; Department of Internal Medicine III, University of Ulm, Ulm, Germany., Becker H; Department of Haematology-Oncology, Faculty of Medicine Freiburg, University of Freiburg Medical Centre, Freiburg, Germany., Greil C; Department of Haematology-Oncology, Faculty of Medicine Freiburg, University of Freiburg Medical Centre, Freiburg, Germany., Reimer P; Evangelisches Krankenhaus Essen-Werden, Essen, Germany., Götze KS; Department of Internal Medicine III, Technical University of Munich, Munich, Germany., Döhner H; Department of Internal Medicine III, University of Ulm, Ulm, Germany., Ganser A; Department of Haematology, Haemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany., Heuser M; Department of Haematology, Haemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany. |
| Source: | British journal of haematology [Br J Haematol] 2018 Oct; Vol. 183 (2), pp. 235-241. |
| Publication Type: | Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
